Cardiovascular disease (CVD) is the primary global cause of death, and inflammation is a
crucial factor in the development of CVDs. The acute phase inflammatory protein pentraxin 3 …

Background: Heart failure is a pathophysiological state, which is still associated with high
morbidity and mortality despite established therapies. Diverse well-known biomarkers fail to …

Background Patients with type 2 diabetes (T2DM) present an increased risk of
cardiovascular (CV) disease and excess CV-related mortality. Beyond the established role …

Aims: While COVID-19 affects the cardiovascular system, the potential clinical impact of
cardiovascular biomarkers on predicting outcomes in COVID-19 patients is still unknown …

Despite all the important advances in its diagnosis and treatment, acute myocardial
infarction (AMI) is still one of the most prominent causes of morbidity and mortality …

Introduction: COVID-19 survivors reveal an increased long-term risk for cardiovascular
disease. Biomarkers like troponins and sST-2 improve stratification of cardiovascular risk …

Objective Findings regarding the prognostic value of soluble suppression of tumorigenecity-
2 (sST2) in patients with coronary artery disease (CAD) remain inconsistent. Therefore, we …

Myocardial ischemia/reperfusion (I/R) injury is associated with high mortality and morbidity,
however, it has no curative treatment. Farrerol (FA), an active compound extracted from …

Новая коронавирусная инфекция (COVID-19) поражает не только органы дыхания, но и
в 20-28% случаев сердечно-сосудистую систему, вызывая дисфункцию эндотелия …

Background. In order to provide personalized medicine and improve cardiovascular
outcomes, a method for predicting adverse left ventricular remodeling (ALVR) after ST …